FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

23621711000001102: Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jan 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
77267901000001118 Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78571501000001114 Relvar Ellipta 184micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) Is a Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler true Inferred relationship Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) Has specific active ingredient Fluticasone furoate true Inferred relationship Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) Has specific active ingredient Vilanterol false Inferred relationship Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) Has dispensed dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) Is a Relvar Ellipta true Inferred relationship Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) Has active ingredient Fluticasone true Inferred relationship Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) Has specific active ingredient Vilanterol true Inferred relationship Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) Has manufactured dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) 30 dose Has AMP True Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start